Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Current Opinion in Oncology
|
November 4, 2010
Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes
Magali Olivier, Philippe Taniere
Cold Spring Harbor Perspectives in Biology
|
February 26, 2010
TP53 mutations in human cancers: origins, consequences, and clinical use
Magali Olivier, Monica Hollstein, Pierre Hainaut
International Journal of Cancer
|
June 16, 2010
p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines
Lynnette Fernandez-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Breast Cancer Research and Treatment
|
March 12, 2010
Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines
Lynnette Fernández-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Cancer
|
August 13, 2011
Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database
Simona Ognjanovic, Magali Olivier, Tracy L Bergemann, et al.
Cancer Letters
|
November 13, 2010
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines
Suresh Anaganti, Lynnette Fernández-Cuesta, Anita Langerød, et al.
Critical Reviews in Clinical Laboratory Sciences
|
December 18, 2004
The tumor suppressor gene TP53: implications for cancer management and therapy
Severine Seemann, Daniela Maurici, Magali Olivier, et al.
Nature Reviews. Cancer
|
September 25, 2012
Upper urinary tract urothelial cancers: where it is A:T
Magali Olivier, Monica Hollstein, Heinz Hans Schmeiser, et al.
Human Mutation
|
January 6, 2006
Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations
Ewy Mathe, Magali Olivier, Shunsuke Kato, et al.
Sarcoma
|
May 3, 2012
Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
Simona Ognjanovic, Ghyslaine Martel, Carlos Manivel, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Current Opinion in Oncology
|
November 4, 2010
Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes
Magali Olivier, Philippe Taniere
Cold Spring Harbor Perspectives in Biology
|
February 26, 2010
TP53 mutations in human cancers: origins, consequences, and clinical use
Magali Olivier, Monica Hollstein, Pierre Hainaut
International Journal of Cancer
|
June 16, 2010
p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines
Lynnette Fernandez-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Breast Cancer Research and Treatment
|
March 12, 2010
Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines
Lynnette Fernández-Cuesta, Suresh Anaganti, Pierre Hainaut, et al.
Cancer
|
August 13, 2011
Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database
Simona Ognjanovic, Magali Olivier, Tracy L Bergemann, et al.
Cancer Letters
|
November 13, 2010
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines
Suresh Anaganti, Lynnette Fernández-Cuesta, Anita Langerød, et al.
Critical Reviews in Clinical Laboratory Sciences
|
December 18, 2004
The tumor suppressor gene TP53: implications for cancer management and therapy
Severine Seemann, Daniela Maurici, Magali Olivier, et al.
Nature Reviews. Cancer
|
September 25, 2012
Upper urinary tract urothelial cancers: where it is A:T
Magali Olivier, Monica Hollstein, Heinz Hans Schmeiser, et al.
Human Mutation
|
January 6, 2006
Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations
Ewy Mathe, Magali Olivier, Shunsuke Kato, et al.
Sarcoma
|
May 3, 2012
Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
Simona Ognjanovic, Ghyslaine Martel, Carlos Manivel, et al.
Page
of 6